Tuesday, November 24, 2009, 5:28AM AEST - The Australian Stockmarket opens in 4 hours and 32 minutes.
To create a watchlist or portfolio of shares, Register

ADDEX PHARMAC N (ADXN.SW)

 3:30AM AEST: 37.50 CHF  Up 0.55 (1.49%)  
 MORE ON ADXN.SW 
Quotes
Charts
Technical Analysis
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
HeadlinesGet Headlines for:
Mon, Nov 16, 2009
•Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
Marketwire (Mon, Nov 16)
Tue, Nov 3, 2009
•Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
Marketwire (Tue, Nov 3)
Mon, Sep 28, 2009
•Addex Completes Enrollment of First Mid-Stage Clinical GERD Trial
Marketwire (Mon, Sep 28)
Thu, Sep 17, 2009
•Laurent Massuyeau, Head of Business Development, Resigns
Marketwire (Thu, Sep 17)
Mon, Sep 14, 2009
•Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
Marketwire (Mon, Sep 14)
Tue, Jul 28, 2009
•Addex Pharmaceuticals Reports First Half 2009 Financial Results
Marketwire (Tue, Jul 28)
Thu, Jul 23, 2009
•Addex First Half 2009 Financial Results Tuesday, July 28
Marketwire (Thu, Jul 23)
Thu, Jul 16, 2009
•Addex R&D Day Highlights Broadened Therapeutic Potential of Allosteric Modulation Platform to Include Cytokine Receptors as Well as GPCRs
Marketwire (Thu, Jul 16)
•Addex R&D Day Highlights Broadened Therapeutic Potential of Allosteric Modulation Platform to Include Cytokine Receptors as Well as GPCRs
Marketwire (Thu, Jul 16)
Fri, Jul 10, 2009
•Addex Achieves Second Milestone in Parkinson's Disease Collaboration With Merck & Co., Inc.
Marketwire (Fri, Jul 10)
•Addex Achieves Second Milestone in Parkinson's Disease Collaboration with Merck & Co., Inc.
Marketwire (Fri, Jul 10)
Fri, Jul 3, 2009
•Addex to Host R&D Day on July 16
Marketwire (Fri, Jul 3)
•Addex to Host R&D Day on July 16
Marketwire (Fri, Jul 3)
Wed, Jun 24, 2009
•Addex Partner Starts First-Ever Clinical Trial of an mGluR Positive Allosteric Modulator
Marketwire (Wed, Jun 24)
•Addex Partner Starts First-Ever Clinical Trial of an mGluR Positive Allosteric Modulator
Marketwire (Wed, Jun 24)
Wed, May 27, 2009
•Glutamate Receptor "mGluR5" Implicated in GERD
Marketwire (Wed, May 27)
•Glutamate Receptor "mGluR5" Implicated in GERD
Marketwire (Wed, May 27)
Thu, Apr 30, 2009
•Addex Presents Data on ADX10059 at the Annual Meeting of the American Academy of Neurology
Marketwire (Thu, Apr 30)
Fri, Apr 17, 2009
•Addex Shareholders Approve All Board Proposals at 2009 AGM
Marketwire (Fri, Apr 17)
Tue, Feb 24, 2009
•Addex Pharmaceuticals 2008 Financial Results
Marketwire (Tue, Feb 24)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
•Latest News•7 Indices